Július Gelžinský

665 total citations
19 papers, 115 citations indexed

About

Július Gelžinský is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Július Gelžinský has authored 19 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Július Gelžinský's work include Blood Pressure and Hypertension Studies (8 papers), Cardiovascular Health and Disease Prevention (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Július Gelžinský is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Cardiovascular Health and Disease Prevention (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Július Gelžinský collaborates with scholars based in Czechia, Netherlands and Poland. Július Gelžinský's co-authors include Jan Filipovský, Jitka Seidlerová, Renata Cífková, Otto Mayer, Štěpán Mareš, Jan Bruthans, Ladislav Trefil, Peter Wohlfahrt, Veronika Svobodová and Martina Cvíčela and has published in prestigious journals such as Journal of Hypertension, Microvascular Research and Nutrition Metabolism and Cardiovascular Diseases.

In The Last Decade

Július Gelžinský

18 papers receiving 112 citations

Peers

Július Gelžinský
Minhazul Mohsin Bangladesh
Beverly Giam Australia
Romain Boulestreau France
Raija Lithovius Finland
G. L. Bartels Netherlands
Marwan Hamaty United States
Łukasz Obrycki Poland
Qiuyu Cao China
Colin Pearce Canada
Sulaiman Sultan United States
Minhazul Mohsin Bangladesh
Július Gelžinský
Citations per year, relative to Július Gelžinský Július Gelžinský (= 1×) peers Minhazul Mohsin

Countries citing papers authored by Július Gelžinský

Since Specialization
Citations

This map shows the geographic impact of Július Gelžinský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Július Gelžinský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Július Gelžinský more than expected).

Fields of papers citing papers by Július Gelžinský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Július Gelžinský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Július Gelžinský. The network helps show where Július Gelžinský may publish in the future.

Co-authorship network of co-authors of Július Gelžinský

This figure shows the co-authorship network connecting the top 25 collaborators of Július Gelžinský. A scholar is included among the top collaborators of Július Gelžinský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Július Gelžinský. Július Gelžinský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cífková, Renata, Joanna Haraźny, Jan Bruthans, et al.. (2023). Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study. Journal of Hypertension. 42(3). 557–563. 1 indexed citations
2.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2022). High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery disease. Nutrition Metabolism and Cardiovascular Diseases. 32(9). 2137–2146. 5 indexed citations
3.
Seidlerová, Jitka, et al.. (2022). Blood pressure response to close or loose contact between physician and patient during attended office blood pressure measurement. Blood Pressure. 31(1). 194–199. 1 indexed citations
4.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2021). Low Vitamin K Status, High Sclerostin and Mortality Risk of Stable Coronary Heart Disease Patients. Biomarkers in Medicine. 15(16). 1465–1477. 5 indexed citations
5.
6.
Mayer, Otto, Július Gelžinský, Jitka Seidlerová, et al.. (2020). The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?. Journal of Human Hypertension. 35(3). 240–249. 18 indexed citations
7.
Mayer, Otto, Jitka Seidlerová, Jan Bruthans, et al.. (2020). Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?. Hormone and Metabolic Research. 52(12). 861–868. 4 indexed citations
8.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2020). The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 540–551. 7 indexed citations
9.
Cífková, Renata, Joanna Haraźny, Jan Bruthans, et al.. (2020). Reference values of retinal microcirculation parameters derived from a population random sample. Microvascular Research. 134. 104117–104117. 7 indexed citations
10.
Mayer, Otto, Jitka Seidlerová, Radek Kučera, et al.. (2020). Synergistic Effect of Sclerostin and Angiotensin Ii Receptor 1 Polymorphism on Arterial Stiffening. Biomarkers in Medicine. 14(3). 173–184. 1 indexed citations
11.
Gelžinský, Július, Otto Mayer, Jitka Seidlerová, et al.. (2019). Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness. Hypertension Research. 43(2). 111–120. 10 indexed citations
12.
Widimský, J, Jan Bruthans, Peter Wohlfahrt, et al.. (2019). PREVALENCE OF PRIMARY ALDOSTERONISM IN A GENERAL POPULATION SAMPLE OF HYPERTENSIVE SUBJECTS. THE CZECH POST-MONICA STUDY. Journal of Hypertension. 37. e219–e219.
13.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2019). The prognostic importance of subclinical heart failure in stable coronary heart disease patients. Acta cardiologica. Supplementum. 75(4). 329–336. 9 indexed citations
14.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2019). Mood disorders impaired quality of life but not the mortality or morbidity risk in stable coronary heart disease patients. PubMed. 75(7). 667–675. 9 indexed citations
15.
16.
Mayer, Otto, et al.. (2018). PO178 The Prospective Study of Education as Additive Mortality Risk Indicator In Chronic Coronary Heart Disease Patients. Global Heart. 13(4). 420–420. 1 indexed citations
17.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2018). The Prognostic Importance of Impaired Fasting Glycemia in Chronic Coronary Heart Disease Patients. Experimental and Clinical Endocrinology & Diabetes. 129(1). 29–35. 1 indexed citations
18.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2018). The changes in achievement of target LDL-cholesterol levels between 2006 and 2017 in Czech patients with chronic coronary heart disease. Cor et Vasa. 61(1). 20–27. 3 indexed citations
19.
Mayer, Otto, Jan Bruthans, Jitka Seidlerová, et al.. (2017). Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients. European Journal of Internal Medicine. 47. 55–61. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minhazul Mohsin Breakdown of academic impact, for papers by Beverly Giam Breakdown of academic impact, for papers by Romain Boulestreau Breakdown of academic impact, for papers by Raija Lithovius Breakdown of academic impact, for papers by G. L. Bartels Breakdown of academic impact, for papers by Marwan Hamaty Breakdown of academic impact, for papers by Łukasz Obrycki Breakdown of academic impact, for papers by Qiuyu Cao Breakdown of academic impact, for papers by Colin Pearce Breakdown of academic impact, for papers by Sulaiman Sultan
Rankless by CCL
2026